Developing digital tissue phantoms for hyperspectral imaging of ischemic wounds by Xu, Ronald X. et al.
Developing digital tissue phantoms for 
hyperspectral imaging of ischemic wounds 
Ronald X. Xu,
1,* David W. Allen,
5 Jiwei Huang,
1 Surya Gnyawali,
2 James Melvin,
1 
Haytham Elgharably,
2 Gayle Gordillo,
2 Kun Huang,
3 Valerie Bergdall,
4  
Maritoni Litorja,
5 Joseph P. Rice,
5 Jeeseong Hwang,
5 and Chandan K. Sen
2 
1Department of Biomedical Engineering, The Ohio State University, Columbus, OH 43210, USA 
2Department of Surgery, The Ohio State University, Columbus, OH 43210, USA 
3Department of Biomedical Informatics, The Ohio State University, Columbus, OH 43210, USA 
4College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA 
5Physical Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, MD 20899, USA 
*xu.202@osu.edu 
Abstract: Hyperspectral imaging has the potential to achieve high spatial 
resolution and high functional sensitivity for non-invasive assessment of 
tissue oxygenation. However, clinical acceptance of hyperspectral imaging 
in ischemic wound assessment is hampered by its poor reproducibility, low 
accuracy, and misinterpreted biology. These limitations are partially caused 
by the lack of a traceable calibration standard. We proposed a digital tissue 
phantom (DTP) platform for quantitative calibration and performance 
evaluation of spectral wound imaging devices. The technical feasibility of 
such a DTP platform was demonstrated by both in vitro  and  in vivo 
experiments. The in vitro DTPs were developed based on a liquid blood 
phantom model. The in vivo  DTPs were developed based on a porcine 
ischemic skin flap model. The DTPs were projected by a Hyperspectral 
Image Projector (HIP) with high fidelity. A wide-gap 2nd derivative 
oxygenation algorithm was developed to reconstruct tissue functional 
parameters from hyperspectral measurements. In this study, we have 
demonstrated not only the technical feasibility of using DTPs for 
quantitative calibration, evaluation, and optimization of spectral imaging 
devices but also its potential for ischemic wound assessment in clinical 
practice. 
© 2012 Optical Society of America 
OCIS codes: (170.0170) Medical optics and biotechnology; (120.4800) Optical standards and 
testing. 
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1. Introduction 
Accurate assessment of wound tissue oxygenation is important for appropriate diagnosis, 
prevention, and treatment of chronic wounds [1,2]. From a diagnostic standpoint, measuring 
wound oxygenation will help in identifying the etiology, staging the disease, and guiding the 
treatment plans in debridement and amputation. From a preventive standpoint,  measuring 
oxygenation in ischemic limbs can follow up wounds to prevent infection and other 
complications. From a therapeutic standpoint, monitoring wound oxygenation will evaluate 
oxygen demand of a given wound and will enable oxygen therapy dosing for personalized 
wound care. 
Hyperspectral imaging opens a new avenue for non-invasive and real-time assessment of 
ischemic wounds. A hyperspectral imager collects a set of images at continuous wavelengths 
to reveal the absorption spectroscopic characteristics of multiple tissue components. Among 
these tissue components, oxygenated hemoglobin and deoxygenated hemoglobin are dominant 
tissue chromophores. Previous studies have demonstrated the technical feasibility for 
hyperspectral imaging of wound oxygenation [3–5]. However, its broader clinical application 
in chronic wound assessment is hindered by several limitations. First of all, many 
hyperspectral wound imaging systems have poor reproducibility and low accuracy. The 
hyperspectral measurements are vulnerable to variations of illumination, detection, and tissue 
surface conditions. Second, many hyperspectral wound imaging systems only provide relative 
information about tissue oxygenation, with significant measurement bias introduced by 
patient-to-patient variations in skin color, blood concentration, and adipose content. Third, 
appropriate interpretation of hyperspectral measurements is challenged by the missing link 
between tissue spectral properties and pathophysiological characteristics. Finally, there is no 
quantitative method to calibrate and evaluate the performance of spectral imaging devices for 
wound assessment. 
One possible reason contributing to the above limitations is the lack of biologically 
relevant calibration standards. Since the hyperspectral imaging technique was originated from 
geological and remote sensing applications, the established calibration protocols are based on 
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tissue morphology, diffuse scattering, background pigmentation, and other biological effects. 
The lack of biologically relevant calibration protocols has hindered the quantitative biological 
interpretation of hyperspectral measurements. The lack of traceable calibration standards has 
contributed to incomparable measurements and patient-to-patient variations for different 
spectral imaging systems. Due to these limitations, it is difficult to establish standard criteria 
for quantitative diagnosis and staging of chronic wounds. 
To facilitate quantitative hyperspectral wound imaging, it is important to develop a 
traceable calibration standard with biological relevancy. An ideal calibration standard should 
have the following characteristics: (1) mimicking the optical properties of biological tissue; 
(2) reproducing the spectral characteristics of wound pathophysiology; (3) long shelf-time 
without degradation or spectral fluctuation; and (4) minimal batch-to-batch variations 
introduced by the fabrication process. In order to satisfy the above design requirements, we 
propose a digital tissue phantom (DTP) platform. A DTP is a hyperspectral data cube 
representing the spectral and functional characteristics of biological tissue. It is generated by 
acquiring hyperspectral data cubes from an actual biological system and reproducing it by a 
hyperspectral image projector (HIP). A DTP is an ideal substitute for a physical calibration 
phantom since it can be projected directly to other spectral imaging devices for system 
calibration and validation. Due to its digital nature, the same DTP can be easily disseminated 
to medical device manufacturers, clinical practitioners, government agencies, and other 
stakeholders in clinical wound management. Compared with a physical phantom standard, a 
DTP system has the potential for providing a biologically relevant, stable, reliable, and 
traceable calibration without concerns of degradation, portability, and manufacturing-induced 
variations. 
In this paper, we will first introduce a hyperspectral image acquisition system and a 
hyperspectral image projector. Then we will demonstrate the proposed DTP platform by both 
an in vitro and an in vivo model. The in vitro model is based on a liquid blood phantom with 
controlled oxygenation levels. The in vivo model is based on porcine ischemic skin flaps. 
Spectral characteristics of both in vitro  and  in vivo  DTPs are reproduced by a National 
Institute of Standards and Technology (NIST) Hyperspectral Image Projector (HIP) system 
and projected to a reference spectrometer with high fidelity. Finally, we will introduce a wide-
gap 2nd derivative oxygenation algorithm for biological interpretation of hyperspectral 
measurements. To the best of the authors’ knowledge, the work described in this paper 
represents the first effort of developing and validating a DTP platform for ischemic wound 
imaging. 
2. Hyperspectral image acquisition 
A PIKA II hyperspectral line scan imager (Resonon, Bozeman, MT) system was used to 
acquire hyperspectral data cubes from both the in vitro and the in vivo models, as shown in 
Fig. 1. The imager is able to acquire spectral reflectance intensities along a line of 640 pixels 
at a spectral resolution of 2 nm. The working wavelength range of the imager is from 400 nm 
to 900 nm. The maximal sampling rate is 50 frames per second. The imager was mounted on a 
motorized linear stage and attached to an optical rail structure through a lockable universal 
joint. As the linear stage translates at the designated step size and speed, the line imager 
acquires a hyperspectral data cube within a designated two-dimensional field of view. A 
broadband halogen lighting system (Resonon, Bozeman, MT) was used to provide a stable 
illumination. The imaging setup was installed on a mobile cart for easy adjustment and quick 
deployment in an operating room. Prior to data acquisition, the system was calibrated 
following a standard procedure of setting exposure, setting focus, setting dark current, and 
setting response correction cube. The response correction cube was calibrated by a Fluorilon 
reflectance standard (Avian Technologies, LLC, Sunapee, NH). The aspect ratio of the 
hyperspectral images was adjusted by tuning the step size of the motorized linear stage.  
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Fig. 1. A hyperspectral imaging setup for benchtop and in vivo  experiments. The system 
consists of a broadband light source, a hyperspectral linear camera, a motorized linear stage, a 
universal joint, and an optical rail structure installed on a mobile cart. 
During a hyperspectral data acquisition session, a standard reference material (SRM) 2044 
NIST traceable white diffuser (NIST, Gaithersburg, MD) was placed next to the sample for 
reflectance reference. 
3. Spectral projection by hyperspectral image projector 
A NIST Hyperspectral Image Projector (HIP) was used to reproduce the spectral 
characteristics of the DTPs. The NIST HIP system was originally developed to support remote 
sensing imager characterization over the solar reflective region (250 nm to 2500 nm) [6]. The 
HIP is based on digital micro-mirror devices (DMDs) which allow for the control of light by 
accepting or rejecting light spatially on a pixel by pixel basis. Spectrally dispersed light 
incident on a DMD can be shaped to produce any arbitrary spectra. The spectra generated on a 
DMD can then be projected onto another DMD used to provide the spatial information by 
controlling the intensity of the full spectrum at each position. The spectral and spatial DMDs 
are cycled through a series of synchronized spectra and grey scale images. The integrated 
result is a scene with full spectral content at each pixel, in effect mimicking reality. The HIP 
can be used to produce a spatially uniform spectral source or alternatively spatially and 
spectrally complex scenes. When the HIP is used to project scenes of the tissue, the output 
product is referred to as a DTP [7]. In general, the HIP is set up to provide spectrally/spatially 
uniform or spectrally/spatially structured information. For cases where only spectral radiance 
is the desired source, an integrating sphere is used as the output optic to provide a spatially 
uniform distribution. For cases where full spatial/spectral scenes are needed, the HIP spatial 
light engine is illuminated, via a liquid light guide from the spectral light engine. 
Since our primary interest is to reproduce the spectral characteristics of biological systems 
with high fidelity, the HIP was set up to provide spatially uniform information. In this 
configuration, an integrating sphere and a spectrometer were used to output and measure the 
optically produced spectra. The HIP was configured to match the spectra obtained from the 
biological system. The reflectance spectra were loaded to the HIP software one at a time to 
match the spectra based on the output from the spectral light engine. 
Figure 2 shows the experimental setup. The output from the spectral light engine of the 
HIP was coupled into an integrating sphere via a liquid light guide. The output from the  
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Fig. 2. The schematic of the HIP experimental setup. The HIP system consists of a VNIR 
spectral light engine, a SWIR spectral light engine, a supercontinuum laser source, and a power 
supply. The output from the spectral light engine is coupled into an integrating sphere and a 
spatial light engine respectively. The output from the integrating sphere is measured by a 
spectrometer. The output from a spatial light engine is detected by a unit-under-test (UUT). 
The UUT could be any spectral imaging devices needing calibration or performance validation. 
spectral light engine was then measured by a FieldSpec spectrometer (ASD Inc, Boulder, Co). 
The ASD FieldSpec was calibrated using NIST scales of spectral radiance. The spectral 
output from the spectral light engine was optimized through an iterative process where the 
figure of merit was the standard deviation of the differences squared. The optimization 
process was allowed to continue until a match of better than 3% was achieved. The typical 
number of iterations required to reach this point was 50 for each of the spectra. In the future 
use, the output of the spectral light engine can also be coupled to a spatial light engine and 
observed by a unit-under-test (UUT). The UUT could be any spectral imaging devices 
needing calibration or performance validation. 
4. Generation of the in vitro DTPs 
4.1. Blood phantom preparation 
In vitro DTPs were generated based on a liquid blood phantom with a total volume of 300 
mL. The phantom was prepared by mixing 4% porcine whole blood, India ink (Sanford, 
Bellwood, IL), and powdered milk solution (Topco Associate LLC, IL) in phosphate buffered 
saline (Fisher Scientific, Newton, NJ). The milk concentration was adjusted in order to reach a 
reduced scattering coefficient of 6.0 cm
−1  (measured at 690 nm), as confirmed by an 
OxiplexTS tissue spectrophotometer (ISS Inc., Champaign, IL). The pH level of the phantom 
was adjusted to 7.4 by adding NaOH and HCl. The oxygenation level of the phantom was 
adjusted by dropwise addition of sodium hydrosulfite (0.025 g/mL) using a syringe pump 
(New Era Pump Systems, Inc, Farmingdale, NY). 
4.2. Hyperspectral data acquisition 
Hyperspectral data cubes were acquired from the above blood phantom using an experimental 
setup as shown in Fig. 3. To eliminate the measurement artifact caused by oxygen in ambient 
air, we placed the blood phantom in a cardboard container and ventilated it with argon gas. 
During the test, 8 oxygenation plateaus ranging from nearly 100% to nearly 0% were achieved 
by dropwise addition of sodium hydrosulfite at the following doses: 0, 0.5, 0.3, 0.3, 0.3, 0.3, 
0.3 and 0.5 mL. At each oxygenation plateau, the blood phantom was mixed to homogeneity 
by a magnetic stirrer and a hyperspectral data cube was acquired at 240 wavelengths from  
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Fig. 3. (a) Schematic drawing of the experimental setup for hyperspectral imaging of a tissue-
simulating phantom. The phantom was placed in a cardboard container ventilated with argon 
gas. Sodium hydrosulfite was added dropwise by a syringe pump to reach different 
oxygenation plateaus. A NIST traceable white diffuser was placed next to the phantom as the 
reflectance reference. A hyperspectral linear camera was driven by a motorized linear stage to 
scan over the whole field of view. The oxygenation level of the phantom was compared with 
the invasive measurements by a tissue oximeter. (b) Blood phantom at full oxygenation. (c) 
Blood phantom at full deoxygenation. The white part on the top of (b) and (c) is the NIST 
traceable white diffuser. 
380 nm to 885 nm by the PIKA II linear scanning imager. As comparison, the oxygenation 
level of the phantom was also measured by the OxiplexTS tissue spectrophotometer. 
4.3. Hyperspectral data projection 
The hyperspectral data cubes acquired from the blood phantom were used as the in vitro 
DTPs. They were transmitted to NIST, projected by a NIST HIP system, and collected by a 
hyperspectral imaging device. To eliminate the spectral bias associated with illuminating and 
detecting conditions, each DTP was projected directly to the hyperspectral imaging device 
with full view pixel-to-pixel mapping. Figures 4(a) and 4(b) show the reflectance spectra of 
the actual phantom at different oxygenation levels and those of the DTPs, respectively. The 
averaged reflectance spectra were calculated from the same region of interest (ROI). Relative 
spectral differences between the blood phantom of different oxygenation levels and the  
 
Fig. 4. (a) Reflectance spectra of the blood phantom at different oxygenation levels ranging 
from 93% to 4%. (b) Reflectance spectra of the corresponding digital phantoms at the same 
oxygenation levels ranging from 93% to 4%. (c) The spectral differences between the blood 
phantom and the digital phantom at different oxygenation levels from 93% to 4%. Reflectance 
spectra in (b) is almost identical to those in (a) at different oxygenation levels, indicating that a 
DTP is able to reproduce the spectral characteristics of the original blood phantom with high 
fidelity. 
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relative spectral deviations between the actual phantom and the DTPs are around ±0.5%, 
indicating that DTPs are capable of reproducing the spectral characteristics of the original 
phantom with high fidelity. 
5. Generation of the in vivo DTPs 
5.1. Animal model preparation 
In vivo DTPs were prepared based on a preclinical model of chronic ischemic wound [8]. The 
animal protocol was approved by the Institutional Lab Animal Care and Use Committee 
(IACUC) at the Ohio State University (OSU) (protocol ID: 2009A0012). A domestic swine 
(~27kg) was anesthetized with Telazol, and the entire dorsal region was shaved. After the skin 
was cleaned with Nolvasan and 70% alcohol, a surgical marking pen was used to mark four 
incision areas of 15 cm x 5 cm in the dorsal region (labeled as “C1”, “C2”, “S1”, and “S2” in 
Fig. 5(a)). Under the aseptic condition, three bipedicle skin flaps were created by making 
parallel incisions along two sides of the marked areas. Two sample dermal flaps (i.e., “S1” 
and “S2”) were created by elevating skin from the underlying tissue and placing silastic sheets 
underneath to prevent the graft bed reperfusion. One control flap (i.e., “C2”) was created by 
the similar procedure except that no silastic sheet was placed. The dermal flaps S1, S2, and C2 
were sutured in place using 3-0 nylon sutures in a continuous pattern. C1 was the blank 
control of normal skin tissue without any incision. After the surgery, the dermal flaps were 
aseptically bandaged to limit  contamination in the cage environment. The animal was 
provided with individual housing (21°C ±2°C; 40%–70% humidity) and standard care in 
accordance with the OSU IACUC guidelines. 
5.2. Hyperspectral data acquisition 
The in vivo hyperspectral imaging tests were carried out at the OSU experimental animal 
surgical services. Hyperspectral data cubes were acquired from the control and the sample 
skin tissues by the hyperspectral linear scanning imager on the first and the third day after the 
skin flap surgery. Before each imaging session, the animal was sedated by Telazol (6 mg/kg) 
and anesthesia was maintained with isofluorane (1%–3%). The animal was first placed in the 
left lateral position with the right dorsal skin flaps exposed for hyperspectral imaging, and 
then switched to the right lateral position to image the skin flaps on the left side. The ambient 
light was shielded in order to minimize the background noise. A PeriFlux 5000 laser Doppler 
and transcutaneous oxygen meter (Perimed Inc., North Royalton, OH) was placed at seven 
spots along each skin flap to measure tissue oxygenation and perfusion levels at these 
positions. By the end of the 3rd day imaging session, the animal was euthanized and the tissue 
biopsies were taken for histopathology analysis. Figures 5(b)–5(c) are RGB images of the 
hyperspectral data cubes acquired on the first day and the 3rd day after surgery from the 
control (i.e., “C1”). Figures 5(d)–5(e)  are those acquired from the sample skin flap (i.e., 
“S2”). A ROI was defined at the center of each hyperspectral data cube, and the reflectance 
spectrum was averaged within the ROI to study the spectral characteristics at different stages 
of a wound healing process. 
Figure 6 shows the reflectance spectra of the control and the sample skin flap acquired on 
the 1st and the 3rd days after surgery. According to Fig. 6(a), the reflectance spectrum of the 
sample skin flap changes significantly due to the developments of ischemia after surgery (red 
lines). However, the reflectance spectrum of the control also fluctuates even if no surgical 
resection has been made (blue lines). The non-specific fluctuation of the control spectrum 
may be caused by dirt, skin color change, surface condition variations, and the change of the 
illumination condition. These non-specific spectral fluctuations need to be eliminated or 
minimized so that the actual tissue hypoxia can be identified. For this purpose, we introduced 
the wide-gap 2nd derivative method for spectral analysis in hyperspectral imaging.  
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Fig. 5. (a) Ischemic skin flaps created in the dorsal area of a domestic pig. S1 and S2 are 
sample dermal flaps created by elevating skin from the underlying tissue and placing silastic 
sheets underneath to prevent the graft bed reperfusion. C2 is the control flap created by the 
similar procedure except that no silastic sheet is placed. C1 is the blank control of normal skin 
tissue without any incision. (b-c) RGB images of the hyperspectral data cubes acquired on the 
1st day (b) and the 3rd day (c) after surgery from the control tissue (“C1”). (d-e) RGB images 
of the hyperspectral data cubes acquired on the 1st day (b) and the 3rd day (e) after surgery 
from the sample tissue (“S2”). 
 
Fig. 6. (a) Reflectance spectra acquired on the 1st and the 3rd days after surgery from the 
control and the sample skin flap. Spectral fluctuations can be observed on both the sample 
ischemic flap and the control. (b) Corresponding wide-gap 2nd derivative spectra. The 2nd 
derivative spectrum of the sample ischemic flap shows significant fluctuation after surgery, 
whereas that of the control tissue shows minimal fluctuation. 
Figure 6(b) shows the 2nd derivative spectra calculated from the conventional reflectance 
spectra in Fig. 6(a). The calculation used a spectral gap of 20 nm. According to Fig. 6(b), the 
2nd derivative reflectance spectrum of the control remains consistent (blue lines), whereas 
that of the sample skin flap alters significantly after surgery (red lines), indicating the 
development of ischemia and hypoxia. 
5.3. Hyperspectral data projection 
The hyperspectral data cubes collected from in vivo porcine tissue were transmitted to NIST 
and projected to a different hyperspectral imaging device by a NIST HIP system. Figures 7(a) 
and 7(b) show the reflectance spectra averaged within 7 ROIs along the ischemic skin flap and 
those of the corresponding DTPs, respectively. The locations of these ROIs are indicated in 
Fig. 5(e). At these ROIs, the relative spectral deviations between the skin tissue and the  
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Fig. 7. (a) Reflectance spectra obtained from the hyperspectral data cubes of the in vivo porcine 
ischemic skin flap at 7 different spots. (b) Reflectance spectra acquired from the corresponding 
in vivo DTPs. The in vivo DTPs were generated by projecting the hyperspectral data cubes 
using a HIP projector. Reflectance spectra in (b) are almost identical to those in (a) at different 
spots, indicating that a DTP is able to reproduce the spectral characteristics of the original 
ischemic skin flap with high fidelity. 
corresponding DTPs were calculated and plotted in Fig. 7(c). According to Fig. 7(c), the 
relative spectral deviations at most of the 7 ROIs are nominally ±0.5% with the exception of 
spot #4. The maximal spectral deviation is observed at spot #4 where tissue ischemia is 
developed with the lowest overall reflectance. Nevertheless, the overall spectral deviations are 
relatively small, indicating that an in vivo  DTP is capable of reproducing the spectral 
characteristics of the original biological tissue with high fidelity. 
6. DTPs for heterogeneous biological systems 
The spectral fidelity of the DTPs generated from heterogeneous biological systems was 
evaluated on both the in vitro blood phantom model and the in vivo porcine skin flap model. 
The reflectance spectra were averaged within each ROI of these models, and the spatial 
deviations were calculated. The HIP system was used to project the averaged reflectance 
spectrum to a spectrometer. The HIP-projected spectrum was compared with the original 
spectrum of the biological system in order to evaluate its spectral fidelity at the presence of 
tissue heterogeneity. 
Figure 8(a) shows the averaged reflectance spectrum of the blood phantom, its spatial 
deviations, and the HIP-projected spectral reflectance (i.e., the DTP). According to Fig. 8(a), 
the DTP matches the reflectance spectrum of the original biological system well. Most of the 
spectral profiles of the DTP fall between the upper and the lower limits of the spatial  
 
Fig. 8. Comparison of the reflectance spectra of the original biological systems and those 
projected by the HIP. (a) Original and HIP-projected reflectance spectra of a blood phantom 
with full oxygenation. (b) Original and HIP-projected reflectance spectra at one ROI in the 
ischemic skin flap. Lower and upper deviations represent the spatial heterogeneity of the 
reflectance spectra. 
0
2
4
6
8
10
12
R
e
f
l
e
c
t
a
n
c
e
 
(
a
.
u
.
)
480 500 520 540 560 580 600 620 640 660 680
Wavelength (nm)
Spot #1
Spot #2
Spot #3
Spot #4
Spot #5
Spot #6
Spot #7
0
2
4
6
8
10
12
R
e
f
l
e
c
t
a
n
c
e
 
(
a
.
u
.
)
480 500 520 540 560 580 600 620 640 660 680
Wavelength (nm)
Spot #1
Spot #2
Spot #3
Spot #4
Spot #5
Spot #6
Spot #7
a b
480 500 520 540 560 580 600 620 640 660 680
Wavelength (nm)
-1.5
-1
-0.5
0
0.5
1
1.5
R
e
l
a
t
i
v
e
 
d
i
f
f
e
r
e
n
c
e
 
(
%
)
Spot #1
Spot #2
Spot #3
Spot #4
Spot #5
Spot #6
Spot #7
c
0
0.7
O
r
i
g
i
n
a
l
 
r
e
f
l
e
c
t
a
n
c
e
 
(
a
.
u
.
)
480 500 520 540 560 580 600 620 640 660 680
Wavelength (nm)
0
35
R
e
p
r
o
d
u
c
e
d
r
e
f
l
e
c
t
a
n
c
e
 
(
a
.
u
.
) Upper deviation of original spectra
Lower deviation of original spectra
Average of original spectra
Reproduced spectra
480 500 520 540 560 580 600 620 640 660 680
Wavelength (nm)
0
0.8
O
r
i
g
i
n
a
l
 
r
e
f
l
e
c
t
a
n
c
e
 
(
a
.
u
.
)
0
15
R
e
p
r
o
d
u
c
e
d
r
e
f
l
e
c
t
a
n
c
e
 
(
a
.
u
.
)
a b
Upper deviation of original spectra
Lower deviation of original spectra
Average of original spectra
Reproduced spectra
#164028 - $15.00 USD Received 2 Mar 2012; revised 3 May 2012; accepted 4 May 2012; published 18 May 2012
(C) 2012 OSA 1 June 2012 / Vol. 3,  No. 6 / BIOMEDICAL OPTICS EXPRESS  1441deviation, indicating that the spectral characteristics reproduced by the DTP could be 
distinguished from the spectral variations due to tissue heterogeneity. Similar results were also 
observed for an ROI in the ischemic skin flap, as shown in Fig. 8(b). According to Figs. 8(a) 
and 8(b), the HIP system is able to reproduce the reflectance spectrum appropriately, with the 
spectral difference smaller than that caused by tissue heterogeneity, indicating the technical 
feasibility of using the HIP-projected DTPs to mimic the original tissue spectra for calibration 
and performance evaluation of medical optical imaging systems. 
7. Reconstruction of tissue oxygenation 
A DTP is capable of preserving functional characteristics of biological tissue without the need 
for a biological sample or a physical phantom. Since the functional properties of biological 
tissue are represented by its spectral characteristics, an appropriate interpretation of these 
spectral characteristics is the key to link hyperspectral measurements with tissue 
pathophysiology. Among a variety of tissue functional parameters, oxygenated hemoglobin 
and deoxygenated hemoglobin are major chromophores contributing to the healing of an 
ischemic wound. Various algorithms have been developed to reconstruct tissue oxygenation 
levels from hyperspectral or multispectral measurements [9–12]. However, many of these 
algorithms calculate the relative changes of tissue oxygenation instead of the absolute values. 
Quantitative assessment of tissue oxygenation is hampered by patient-to-patient variations in 
skin color, tissue pigmentation, background absorption, blood concentration, and lipid 
content. In order to facilitate quantitative calibration and performance evaluation of spectral 
imaging devices in wound assessment, it is necessary to reconstruct tissue oxygenation levels 
with minimal patient-to-patient biases. 
7.1. Algorithm development 
We explored a wide-gap 2nd derivative algorithm for hyperspectral imaging of tissue 
oxygenation [5]. The algorithm takes the 2nd derivative of a reflectance spectrum so that non-
specific variations in tissue scattering and background absorption can be minimized or even 
eliminated [13,14]. Once the wide-gap 2nd derivative reflectance spectrum is obtained, tissue 
oxygen saturation can be reconstructed by various hyperspectral oximetry methods at the 
selected spectral bands. The frequently used hyperspectral oximetry algorithms include 
principal component analysis, fuzzy C-means  clustering, the Gaussian superposition, 
multivariate analysis, least-squares regression, and Monte Carlo simulation [9,10,12,15]. 
A forward model and an inverse model of the oxygenation algorithm were implemented in 
MATLAB (MathWorks, Natick, MA). The forward model simulated the diffuse reflectance 
spectra of a blood phantom by modeling light transport in a semi-infinite turbid media with 
the following parameters: 1% of intralipid concentration, 5% of whole blood concentration, 
reduced scattering coefficient of 5.2 cm
−1  (measured at 690 nm), and the India ink 
concentrations simulating the melanin content in white, yellow, and black skins, respectively. 
As to the inverse algorithm, the 2nd derivative reflectance spectrum with a wavelength gap of 
20 nm was obtained from the simulated measurements. A least-squares linear regression 
method was then used to derive the correlation between the oxygenation levels and the 
spectral characteristics within the selected wavelength band. In order to test the robustness of 
the inverse algorithm for real-world applications, the simulated measurements were combined 
with two types of noises. Type I noise is the white noise associated with material 
concentration, with the assumption that the chemical composition of the phantom is known 
but the concentration of each ingredient is inaccurate (with up to ±20% variations in material 
concentration). Type II noise is the white noise associated with material composition, with the 
assumption that the chemical composition of the phantom is unknown (with up to 10% 
variations in background absorption and scattering spectra). Figures 9(a) shows the actual 
oxygenation levels versus those reconstructed from the simulated measurements with 20% of 
type I noise in absorption and scattering background. According to Fig. 9(a), the inverse 
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potential for reliable measurement of tissue oxygenation regardless of variations in skin color 
and adipose tissue content. Figure 9(b)  shows the actual oxygenation levels versus those 
reconstructed from the simulated measurements with up to 10% of type II noise in absorption 
and scattering background. According to Fig. 9(b), the inverse algorithm is accurate at the 
oxygenation level above 60%. However, at the oxygenation level lower than 60%, the inverse 
algorithm tends to underestimate the oxygenation values. 
 
Fig. 9. (a) Actual oxygenation levels versus oxygenation levels reconstructed from the wide-
gap 2nd derivative spectra based on the simulated measurements. 20% of type I noise is 
introduced into the simulated measurements. (b) Actual versus reconstructed oxygenation 
levels for the simulated measurements where up to 10% of type II noise is introduced in the 
absorption and scattering spectra. 
7.2. Algorithm validation 
The oxygenation algorithm was validated on the liquid blood phantom as shown in Fig. 3. 
Hyperspectral images were acquired from both the physical phantom and the corresponding 
DTPs at different oxygenation levels. The reflectance spectra were obtained by averaging the 
same ROI in these phantoms. Figure 10 shows the oxygenation levels reconstructed from the 
original measurements and from the corresponding DTPs. Linear correlation is observed 
between the calculated oxygenation levels and their actual values, indicating that the inverse 
algorithm is able to reconstruct tissue oxygenation. Furthermore, the oxygenation levels 
reconstructed from the DTPs are consistent with those from the original measurements, 
indicating that the DTPs are able to preserve the functional characteristics of the original 
phantom. Our next step work is to validate the oxygenation algorithm in the in vivo porcine 
ischemic skin flap model. Oxygenation levels reconstructed from both the original and the 
DTP spectra at different locations of the skin flap will be compared side by side with the 
oxygen tension and perfusion measurements at the same locations to determine the accuracy 
for oxygenation reconstruction. 
8. Discussion and conclusions 
We have studied the technical feasibility of using digital tissue phantoms (DTPs) to preserve 
functional characteristics of in vitro and in vivo biological systems. We have also explored a 
wide-gap 2nd derivative algorithm to reconstruct tissue oxygenation from the hyperspectral 
data cubes. In this study, we have demonstrated not only the technical feasibility of using 
DTPs for quantitative calibration, evaluation, and optimization of spectral imaging devices but 
also the potential for ischemic wound assessment in clinical practice. 
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Fig. 10. Actual phantom oxygenation levels measured by a tissue oximeter versus those 
reconstructed from the original hyperspectral measurements (blue circles) and from the 
projected DTPs (green triangles). The solid redline is a 1:1 diagonal line. The reconstructed 
oxygenation values have been  normalized to the scale of 0 to 100. Linear correlation is 
observed between the reconstructed and the actual oxygenation levels. The error bars indicate 
the oxygen heterogeneity of the tested blood phantom. 
In our current design, a DTP is directly projected to a spectral imaging device by a HIP 
system with pixel-to-pixel mapping in the whole field of view. This configuration eliminates 
the imaging artifacts associated with different illumination and detection conditions. 
Therefore, a DTP is able to reproduce the spectral reflectance of the original biological system 
with high fidelity. In the meantime, the current DTP design has to overcome several 
limitations before it can be adopted as a calibration standard for biomedical optical imaging 
devices. The first limitation is associated with the coupling of the specular reflectance, the 
diffuse reflectance, and the shadowing effect in a hyperspectral data cube. In order to establish 
a calibration standard independent of the test condition, it is necessary to eliminate or at least 
minimize the specular reflectance and the shadowing effect. The other limitation is associated 
with biological interpretation of hyperspectral measurements. The oxygenation algorithm we 
are currently implementing is based on spectral analysis without solving the inverse problem 
of light transport in biological tissue. This approach assumes the negligible multi-scattering 
effect owing to the limited penetration depth of the visible light. Although spectral analysis 
has been used by many reflectometry devices [16], it may not provide the required accuracy 
for biological interpretation of a DTP standard. Numerical tools, such as a multi-layer Monte 
Carlo modeling [17], may be used to simulate the light transport in a multi-layered DTP. The 
simulation will help to optimize the wavelength band of DTP for minimal scattering-induced 
bias. Further advancements in imaging techniques and inverse algorithms are also required for 
accurate reconstruction of biological parameters from optical measurements. 
The DTP can provide medical images with realistic spatial and spectral content that can be 
used in evaluating optical medical imaging devices. This can greatly reduce the costs 
associated with running live experiments on volunteers in addition to conveniently providing 
a consistent scene. It is anticipated that the DTP will be used not only in device development 
but also as a validation tool at the end of assembly lines and in the clinic. As the HIP 
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projection. The time lapse may be on the order of seconds in order to take into account the 
pulse from a heartbeat or on the order of days in order to show the progression of the healing 
of wounds. Overall, the DTP will advance the ability to evaluate the performance of spectral 
imagers that will be used in future healthcare. 
By integrating with microscopy techniques, the 2D projected hyperspectral image from the 
HIP could be focused onto a microscope sample slide. This opens up a range of possibilities in 
clinical pathology as well which was not possible with conventional uniform-field microscope 
illuminators, since now the illuminating spectrum and irradiance level at each region of 
interest of the specimen can be independently and dynamically controlled in vitro and in vivo. 
This approach is expected to enhance the dynamic range of the image contrast and to mitigate 
potential photo-induced damage to live tissues. 
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